Scarica l'app Stockscreener
5.01
2.66%
0.13
Pre-mercato:
4.96
-0.05
-1.00%
Precedente Chiudi:
$4.88
Aprire:
$5
Volume 24 ore:
65,065
Relative Volume:
0.62
Capitalizzazione di mercato:
$359.67M
Reddito:
$81.18M
Utile/perdita netta:
$-80.94M
Rapporto P/E:
-4.2425
EPS:
-1.1809
Flusso di cassa netto:
$-55.15M
1 W Prestazione:
-5.11%
1M Prestazione:
+8.21%
6M Prestazione:
+6.14%
1 anno Prestazione:
+74.56%
Intervallo 1D:
$4.895
$5.13
Intervallo di 1 settimana:
$4.81
$5.50
Portata 52W:
$2.59
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Nome
Sophia Genetics Sa
Settore
Industria
Telefono
-
Indirizzo
-
Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.01 | 359.67M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
162.17 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Craig Hallum | Buy |
| 2024-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-03 | Iniziato | BTIG Research | Buy |
| 2022-11-23 | Iniziato | Credit Suisse | Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-17 | Iniziato | Cowen | Outperform |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-08-17 | Iniziato | JP Morgan | Overweight |
| 2021-08-17 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sophia Genetics Sa Borsa (SOPH) Ultime notizie
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus
SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under Rule 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) Slides 6% as Selling Pressure Tests Key Support ZoneCash Secured Put - newsline.com
Insider Sell Alert: Jurgi Camblong Sells 8,500 Shares of Sophia Genetics SA (SOPH) - GuruFocus
Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (SOPH) CEO sells 8,500 shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting - Financial Times
Insider Spends US$99k Buying More Shares In SOPHiA GENETICS - Yahoo Finance
Insider Buying: George Cardoza Acquires 20,000 Shares of Sophia Genetics SA - GuruFocus
[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan
SOPH News | SOPHIA GENETICS SA (NASDAQ:SOPH) - ChartMill
BTIG reiterates Sophia Genetics stock rating on strong Q1 growth - Investing.com
SOPH: AI-driven precision medicine platform accelerates global growth and innovation in genomic analysis - TradingView
SOPHiA GENETICS (NASDAQ: SOPH) and MSK plan precision oncology hub MOU - Stock Titan
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center - marketscreener.com
AI cancer hub in the works as SOPHiA GENETICS teams with MSK - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,750.00 in Stock - MarketBeat
CMO of SOPHiA GENETICS (SOPH) sells 5,000 shares under Rule 10b5-1 plan - Stock Titan
SOPHiA Genetics inks two deals to advance AI for precision medicine - MSN
SOPHiA GENETICS (SOPH) Quarterly Losses Test Bullish Growth Narrative Despite Revenue Progress - Sahm
Undervalued Opportunities: Top Penny Stocks To Watch In May 2026 - Sahm
SOPHiA GENETICS (SOPH) president’s 761-share tax sale under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CSO sells shares to cover RSU tax via 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CMO pre-planned sale of 608 shares for tax - Stock Titan
Tax-driven sale: SOPHiA GENETICS (SOPH) CLO disposes 684 shares - Stock Titan
SOPHiA GENETICS (SOPH) CPO sells 380 shares to cover RSU taxes - Stock Titan
SOPHiA GENETICS (SOPH) CSO sells 33 shares in tax sell-to-cover - Stock Titan
JURGI CAMBLONG sells shares under 10b5-1 (SOPH) - Stock Titan
Manuela Valente files Form 144 to sell SOPH shares (NASDAQ: SOPH) - Stock Titan
SOPH (NASDAQ) insider RSUs recorded; Philippe Menu reports multiple 10b5-1 sales - Stock Titan
761 RSUs filed; prior 10b5-1 sales by Ross J Muken (SOPH) - Stock Titan
Form 144: 684 RSUs flagged for sale by Morgan Stanley Smith Barney (SOPH) - Stock Titan
Rule 144: Officer/holder lists 4,608 RSUs for sale (SOPH) - Stock Titan
SOPHiA GENETICS Files Form 6-K and Publishes 2025 ESG Impact Summary - TipRanks
SOPHiA GENETICS (SOPH) publishes 2025 ESG Impact Summary for investors - Stock Titan
SOPHiA GENETICS (SOPH) CSO executes 4,000-share sale under 10b5-1 plan - Stock Titan
Director Kathy Hibbs sells SOPHiA GENETICS (SOPH) shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CMO pre-planned sale of 5,000 shares - Stock Titan
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. - marketscreener.com
New NHS blood test aims to speed lung and breast cancer treatment - Stock Titan
SOPHiA GENETICS (SOPH) CEO 10b5-1 sale of 8,500 shares - Stock Titan
TradingKey - tradingkey.com
How SOPHiA (SOPH) performance reflects its true potential (-4.63%) 2026-05-08Macro Trends - Newser
SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland - Investing.com Nigeria
SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland By Investing.com - Investing.com South Africa
SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth - TipRanks
Leadership change and pay votes at SOPHiA GENETICS (Nasdaq: SOPH) - Stock Titan
SOPHiA GENETICS SA 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-05-07 - Seeking Alpha
SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research - MarketBeat
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG reiterates Sophia Genetics stock rating on strong Q1 growth By Investing.com - Investing.com Australia
Sophia Genetics Sa Azioni (SOPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):